These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 34589481)
1. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma. Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481 [TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
3. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer. Xu LC; Pan JX; Pan HD Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956 [TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma. Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211 [No Abstract] [Full Text] [Related]
5. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma. Pan J; Xu L; Pan H Front Oncol; 2020; 10():1444. PubMed ID: 32974164 [No Abstract] [Full Text] [Related]
6. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma. Qi LW; Jia JH; Jiang CH; Hu JM Front Genet; 2020; 11():614566. PubMed ID: 33519919 [TBL] [Abstract][Full Text] [Related]
7. Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma. Bai Z; Wang X; Zhang Z Front Genet; 2022; 13():655169. PubMed ID: 35281815 [No Abstract] [Full Text] [Related]
8. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma. Wu X; Zhang X; Tao L; Dai X; Chen P Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931 [TBL] [Abstract][Full Text] [Related]
9. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Miao C; Fang X; Chen Y; Zhao Y; Guo Q Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221 [TBL] [Abstract][Full Text] [Related]
10. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis. Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690 [TBL] [Abstract][Full Text] [Related]
12. MrGPS: an m6A-related gene pair signature to predict the prognosis and immunological impact of glioma patients. Zhang N; Yang F; Zhao P; Jin N; Wu H; Liu T; Geng Q; Yang X; Cheng L Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38171932 [TBL] [Abstract][Full Text] [Related]
13. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets. Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805 [No Abstract] [Full Text] [Related]
14. Prognosis Analysis and Validation of m Lin S; Xu H; Zhang A; Ni Y; Xu Y; Meng T; Wang M; Lou M Front Oncol; 2020; 10():541401. PubMed ID: 33123464 [TBL] [Abstract][Full Text] [Related]
15. The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer. Zhu W; Zhao L; Kong B; Liu Y; Zou X; Han T; Shi Y Ann Transl Med; 2022 Jan; 10(2):59. PubMed ID: 35282121 [TBL] [Abstract][Full Text] [Related]
16. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation. Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253 [TBL] [Abstract][Full Text] [Related]
17. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma. Wang Z; Cheng H; Xu H; Yu X; Sui D Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634 [TBL] [Abstract][Full Text] [Related]
18. Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma. Du J; Hou K; Mi S; Ji H; Ma S; Ba Y; Hu S; Xie R; Chen L Front Oncol; 2020; 10():208. PubMed ID: 32211315 [TBL] [Abstract][Full Text] [Related]
19. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma. Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K Front Oncol; 2020; 10():1119. PubMed ID: 32974125 [No Abstract] [Full Text] [Related]
20. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma. Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]